HIGHLIGHTS
- who: Linying Wu and collaborators from the Department of Respiratory Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China have published the Article: TROY Modulates Cancer Stem-Like Cell Properties and Ge tinib Resistance Through EMT Signaling in Non - Small Cell Lung Cancer, in the Journal: (JOURNAL)
- what: The authors established gefitinib, the firstgeneration EGFR-TKI, resistant cell line, which with no targetable mutations to explore the other mechanisms of EGFR-TKI resistance.
- how: Clinical data were analyzed using the chi-squared test or the two-sided Student`s t . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.